Abstract:Endometriosis is a medical condition affecting at least up to 10% of women of reproductive age. This condition occurs when ectopic endometrial glands and stroma implant outside the uterus and there are several theories regarding the underlying origins of the disease. Endometriosis is one of the major causes of severe dysmenorrhoea, chronic pelvic pain and infertility. While endometriosis is generally a non-malignant condition, it rarely may transform into an invasive cancer, and increase the risk for epithelial ovarian cancer, notably endometrioid or clear cell ovarian cancer. Despite the increased risk, the mechanisms behind the development of endometriosis-associated ovarian cancer (EAOC) are not yet well understood. Recent investigations have delved into the intricate interplay between endometriosis and EAOC, exploring pathways involving oxidative stress, inflammation, hyperestrogenism, and the discovery of genetic mutations within endometriotic lesions that hint at a transition towards invasive carcinoma. Efforts have been made to identify intermediary lesions between endometriosis and EAOC, which may enable earlier detection of endometriosis at risk of malignant transformation or even prevention of the transformation altogether. However, given the rarity of this malignancy, there is still the risk of late or missed diagnosis, with the risk of inappropriate management being offered to the patient, and the higher risk of poor prognosis and increased morbidity and mortality. This scoping review aims to summarize existing data on EAOC, with a focus on endometrioid and clear cell histologic subtypes. It also provides insights into its identification, prognosis, and delineating management strategies, seeking to provide a holistic understanding of the complexities surrounding EAOC, facilitating further research and the development of more effective prevention and treatment approaches.

New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment

Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy

Advances in research on malignant transformation of endometriosis-associated ovarian cancer

Research progress in endometriosis-associated ovarian cancer

Rare but Still There: A Scoping Review on Endometriosis-Associated Ovarian Cancer

From Molecular Pathologies to Clinical Relevance

Clinicopathological characteristics, molecular features and novel diagnostic strategies for the detection of malignant transformation of endometriosis (Review)

Genetic Links between Endometriosis and Endometriosis-Associated Ovarian Cancer—A Narrative Review (Endometriosis-Associated Cancer)

Research progress on correlative prediction factors and prediction models of endometriosis associated ovarian carcinoma

Progress in Research of Tumor Microenvironment in Endometrial Cancer

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma

Ovarian Endometriosis: Risk Factor Analysis and Prediction of Malignant Transformation.

A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer

Where Are We Now? A Narrative Review towards a Pragmatic Approach

Endometriosis: A Malignant Fingerprint

Endometriosis and Ovarian Cancer: Should we be worried? Five Cases Report and Literature Review

Abstract IA009: Epigenetic approaches to endometriosis-associated ovarian cancer

Impacts of endometrioma on ovarian aging from basic science to clinical management

Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer

Improved Clinical Outcomes of Patients with Ovarian Carcinoma Arising in Endometriosis